Jain Neeranjali, Fan Gaskin Jennifer C
Glaucoma Research and Investigation Unit, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.
Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.
Clin Exp Ophthalmol. 2025 Jun 18. doi: 10.1111/ceo.14571.
The advent of minimally invasive glaucoma surgery (MIGS) has expanded the treatment options available for glaucoma by providing options for reducing intraocular pressure without the serious complication profile associated with incisional glaucoma surgery. MIGS devices aim to enhance aqueous outflow through the trabecular pathway or to bypass this pathway with drainage of fluid into the suprachoroidal or subconjunctival spaces. Having a wide range of glaucoma treatment options available helps tailor treatment to patients' individual intraocular pressure targets and aetiologies of glaucoma. This review will describe the categories and mechanisms of MIGS, comment on their relative efficacies, safety data, advantages and limitations and explore potential future changes in the glaucoma treatment paradigm in relation to MIGS.
微创青光眼手术（MIGS）的出现扩大了青光眼的治疗选择，它提供了降低眼压的方法，且没有与切口性青光眼手术相关的严重并发症。MIGS设备旨在通过小梁途径增强房水流出，或通过将液体引流到脉络膜上腔或结膜下间隙来绕过该途径。拥有广泛的青光眼治疗选择有助于根据患者的个体眼压目标和青光眼病因来定制治疗方案。本综述将描述MIGS的类别和机制，评论其相对疗效、安全性数据、优点和局限性，并探讨与MIGS相关的青光眼治疗模式未来可能的变化。
